-
1
-
-
0032481410
-
Low dosage and long treatment duration of beta-lactam: risk factors for carriage of penicillin-resistant Streptococcus pneumoniae
-
Guillemot D., Carbon C., Balkau B., Geslin P., Lecoeur H., Vauzelle-Kervroedan F., et al. Low dosage and long treatment duration of beta-lactam: risk factors for carriage of penicillin-resistant Streptococcus pneumoniae. JAMA 279 5 (1998) 365-370
-
(1998)
JAMA
, vol.279
, Issue.5
, pp. 365-370
-
-
Guillemot, D.1
Carbon, C.2
Balkau, B.3
Geslin, P.4
Lecoeur, H.5
Vauzelle-Kervroedan, F.6
-
2
-
-
33646823492
-
Pharmacodynamics: relation to antimicrobial resistance
-
Rybak M.J. Pharmacodynamics: relation to antimicrobial resistance. Am J Med 119 6 Suppl. 1 (2006) S37-S44
-
(2006)
Am J Med
, vol.119
, Issue.6 SUPPL. 1
-
-
Rybak, M.J.1
-
3
-
-
2442549489
-
Relationship between fluoroquinolone area under the curve: minimum inhibitory concentration ratio and the probability of eradication of the infecting pathogen, in patients with nosocomial pneumonia
-
Drusano G.L., Preston S.L., Fowler C., Corrado M., Weisinger B., and Kahn J. Relationship between fluoroquinolone area under the curve: minimum inhibitory concentration ratio and the probability of eradication of the infecting pathogen, in patients with nosocomial pneumonia. J Infect Dis 189 9 (2004) 1590-1597
-
(2004)
J Infect Dis
, vol.189
, Issue.9
, pp. 1590-1597
-
-
Drusano, G.L.1
Preston, S.L.2
Fowler, C.3
Corrado, M.4
Weisinger, B.5
Kahn, J.6
-
4
-
-
0033628622
-
Pharmacodynamic modeling of risk factors for ciprofloxacin resistance in Pseudomonas aeruginosa
-
Hyatt J.M., and Schentag J.J. Pharmacodynamic modeling of risk factors for ciprofloxacin resistance in Pseudomonas aeruginosa. Infect Control Hosp Epidemiol 21 Suppl. 1 (2000) S9-S11
-
(2000)
Infect Control Hosp Epidemiol
, vol.21
, Issue.SUPPL. 1
-
-
Hyatt, J.M.1
Schentag, J.J.2
-
5
-
-
1642277881
-
Gatifloxacin 200 mg or 400 mg once daily is as effective as ciprofloxacin 500 mg twice daily for the treatment of patients with acute pyelonephritis or complicated urinary tract infections
-
Naber K.G., Bartnicki A., Bischoff W., Hanus M., Milutinovic S., van Belle F., et al. Gatifloxacin 200 mg or 400 mg once daily is as effective as ciprofloxacin 500 mg twice daily for the treatment of patients with acute pyelonephritis or complicated urinary tract infections. Int J Antimicrob Agents 23 Suppl. 1 (2004) S41-S53
-
(2004)
Int J Antimicrob Agents
, vol.23
, Issue.SUPPL. 1
-
-
Naber, K.G.1
Bartnicki, A.2
Bischoff, W.3
Hanus, M.4
Milutinovic, S.5
van Belle, F.6
-
6
-
-
1942534571
-
Efficacy of 750-mg, 5-day levofloxacin in the treatment of community-acquired pneumonia caused by atypical pathogens
-
Dunbar L.M., Khashab M.M., Kahn J.B., Zadeikis N., Xiang J.X., and Tennenberg A.M. Efficacy of 750-mg, 5-day levofloxacin in the treatment of community-acquired pneumonia caused by atypical pathogens. Curr Med Res Opin 20 4 (2004) 555-563
-
(2004)
Curr Med Res Opin
, vol.20
, Issue.4
, pp. 555-563
-
-
Dunbar, L.M.1
Khashab, M.M.2
Kahn, J.B.3
Zadeikis, N.4
Xiang, J.X.5
Tennenberg, A.M.6
-
7
-
-
0028909402
-
Short-course ciprofloxacin treatment of acute uncomplicated urinary tract infection in women. The minimum effective dose. The Urinary Tract Infection Study Group [corrected]
-
Iravani A., Tice A.D., McCarty J., Sikes D.H., Nolen T., Gallis H.A., et al. Short-course ciprofloxacin treatment of acute uncomplicated urinary tract infection in women. The minimum effective dose. The Urinary Tract Infection Study Group [corrected]. Arch Intern Med 155 5 (1995) 485-494
-
(1995)
Arch Intern Med
, vol.155
, Issue.5
, pp. 485-494
-
-
Iravani, A.1
Tice, A.D.2
McCarty, J.3
Sikes, D.H.4
Nolen, T.5
Gallis, H.A.6
-
8
-
-
0027418044
-
Randomized double-blind trial of high- and low-dose fleroxacin versus norfloxacin for complicated urinary tract infection
-
Pittman W., Moon J.O., Hamrick Jr. L.C., Cox C.E., Clark J., Childs S., et al. Randomized double-blind trial of high- and low-dose fleroxacin versus norfloxacin for complicated urinary tract infection. Am J Med 94 3A (1993) 101S-104S
-
(1993)
Am J Med
, vol.94
, Issue.3 A
-
-
Pittman, W.1
Moon, J.O.2
Hamrick Jr., L.C.3
Cox, C.E.4
Clark, J.5
Childs, S.6
-
9
-
-
0033631281
-
Potential role of pharmacokinetics, pharmacodynamics, and computerized databases in controlling bacterial resistance
-
Hyatt J.M., and Schentag J.J. Potential role of pharmacokinetics, pharmacodynamics, and computerized databases in controlling bacterial resistance. Infect Control Hosp Epidemiol 21 Suppl. 1 (2000) S18-S21
-
(2000)
Infect Control Hosp Epidemiol
, vol.21
, Issue.SUPPL. 1
-
-
Hyatt, J.M.1
Schentag, J.J.2
-
10
-
-
0031940776
-
Pharmacodynamic evaluation of factors associated with the development of bacterial resistance in acutely ill patients during therapy
-
Thomas J.K., Forrest A., Bhavnani S.M., Hyatt J.M., Cheng A., Ballow C.H., et al. Pharmacodynamic evaluation of factors associated with the development of bacterial resistance in acutely ill patients during therapy. Antimicrob Agents Chemother 42 3 (1998) 521-527
-
(1998)
Antimicrob Agents Chemother
, vol.42
, Issue.3
, pp. 521-527
-
-
Thomas, J.K.1
Forrest, A.2
Bhavnani, S.M.3
Hyatt, J.M.4
Cheng, A.5
Ballow, C.H.6
-
11
-
-
0030724627
-
Comparison of two regimens for ciprofloxacin treatment of enteric infections
-
Agalar C., Usubutun S., Tutuncu E., and Turkyilmaz R. Comparison of two regimens for ciprofloxacin treatment of enteric infections. Eur J Clin Microbiol Infect Dis 16 11 (1997) 803-806
-
(1997)
Eur J Clin Microbiol Infect Dis
, vol.16
, Issue.11
, pp. 803-806
-
-
Agalar, C.1
Usubutun, S.2
Tutuncu, E.3
Turkyilmaz, R.4
-
12
-
-
0022851507
-
Clinical efficacy of ofloxacin in the treatment of otorhinolaryngological infections
-
Baba S. Clinical efficacy of ofloxacin in the treatment of otorhinolaryngological infections. Infection 14 Suppl. 4 (1986) S327-S331
-
(1986)
Infection
, vol.14
, Issue.SUPPL. 4
-
-
Baba, S.1
-
13
-
-
0023895078
-
Evaluation of 500- and 1,000-mg doses of ciprofloxacin for the treatment of chancroid
-
Bodhidatta L., Taylor D.N., Chitwarakorn A., Kuvanont K., and Echeverria P. Evaluation of 500- and 1,000-mg doses of ciprofloxacin for the treatment of chancroid. Antimicrob Agents Chemother 32 5 (1988) 723-725
-
(1988)
Antimicrob Agents Chemother
, vol.32
, Issue.5
, pp. 723-725
-
-
Bodhidatta, L.1
Taylor, D.N.2
Chitwarakorn, A.3
Kuvanont, K.4
Echeverria, P.5
-
14
-
-
0024419440
-
Dose-ranging study of fleroxacin for treatment of uncomplicated Chlamydia trachomatis genital infections
-
Bowie W.R., Willetts V., and Megran D.W. Dose-ranging study of fleroxacin for treatment of uncomplicated Chlamydia trachomatis genital infections. Antimicrob Agents Chemother 33 10 (1989) 1774-1777
-
(1989)
Antimicrob Agents Chemother
, vol.33
, Issue.10
, pp. 1774-1777
-
-
Bowie, W.R.1
Willetts, V.2
Megran, D.W.3
-
15
-
-
0027512978
-
Treatment of acute bacterial diarrhea: a multicenter international trial comparing placebo with fleroxacin given as a single dose or once daily for 3 days
-
Butler T., Lolekha S., Rasidi C., Kadio A., del Rosal P.L., Iskandar H., et al. Treatment of acute bacterial diarrhea: a multicenter international trial comparing placebo with fleroxacin given as a single dose or once daily for 3 days. Am J Med 94 3A (1993) 187S-194S
-
(1993)
Am J Med
, vol.94
, Issue.3 A
-
-
Butler, T.1
Lolekha, S.2
Rasidi, C.3
Kadio, A.4
del Rosal, P.L.5
Iskandar, H.6
-
16
-
-
0032973962
-
Clinical effectiveness of levofloxacin in patients with acute purulent exacerbations of chronic bronchitis: the relationship with in-vitro activity
-
Davies B.I., and Maesen F.P. Clinical effectiveness of levofloxacin in patients with acute purulent exacerbations of chronic bronchitis: the relationship with in-vitro activity. J Antimicrob Chemother 43 Suppl. C (1999) 83-90
-
(1999)
J Antimicrob Chemother
, vol.43
, Issue.SUPPL. C
, pp. 83-90
-
-
Davies, B.I.1
Maesen, F.P.2
-
17
-
-
0036239477
-
Pharmacokinetic parameters of ciprofloxacin (500 mg/5 mL). Oral suspension in critically ill patients with severe bacterial pneumonia: a comparison of two dosages
-
Debon R., Breilh D., Boselli E., Saux M.C., Duflo F., Chassard D., et al. Pharmacokinetic parameters of ciprofloxacin (500 mg/5 mL). Oral suspension in critically ill patients with severe bacterial pneumonia: a comparison of two dosages. J Chemother 14 2 (2002) 175-180
-
(2002)
J Chemother
, vol.14
, Issue.2
, pp. 175-180
-
-
Debon, R.1
Breilh, D.2
Boselli, E.3
Saux, M.C.4
Duflo, F.5
Chassard, D.6
-
18
-
-
0141676184
-
High-dose, short-course levofloxacin for community-acquired pneumonia: a new treatment paradigm
-
Dunbar L.M., Wunderink R.G., Habib M.P., Smith L.G., Tennenberg A.M., Khashab M.M., et al. High-dose, short-course levofloxacin for community-acquired pneumonia: a new treatment paradigm. Clin Infect Dis 37 6 (2003) 752-760
-
(2003)
Clin Infect Dis
, vol.37
, Issue.6
, pp. 752-760
-
-
Dunbar, L.M.1
Wunderink, R.G.2
Habib, M.P.3
Smith, L.G.4
Tennenberg, A.M.5
Khashab, M.M.6
-
19
-
-
0023630774
-
Use of norfloxacin in the treatment of acute diarrheal disease
-
Dupont H.L., Corrado M.L., and Sabbaj J. Use of norfloxacin in the treatment of acute diarrheal disease. Am J Med 82 6B (1987) 79-83
-
(1987)
Am J Med
, vol.82
, Issue.6 B
, pp. 79-83
-
-
Dupont, H.L.1
Corrado, M.L.2
Sabbaj, J.3
-
20
-
-
5444275363
-
Clinical implications of 750 mg, 5-day levofloxacin for the treatment of community-acquired pneumonia
-
File Jr. T.M., Milkovich G., Tennenberg A.M., Xiang J.X., Khashab M.M., and Zadeikis N. Clinical implications of 750 mg, 5-day levofloxacin for the treatment of community-acquired pneumonia. Curr Med Res Opin 20 9 (2004) 1473-1481
-
(2004)
Curr Med Res Opin
, vol.20
, Issue.9
, pp. 1473-1481
-
-
File Jr., T.M.1
Milkovich, G.2
Tennenberg, A.M.3
Xiang, J.X.4
Khashab, M.M.5
Zadeikis, N.6
-
21
-
-
0028105983
-
Study of the efficacy and safety of ciprofloxacin in the treatment of chronic otitis
-
Fombeur J.P., Barrault S., Koubbi G., Laurier J.N., Ebbo D., Lecomte F., et al. Study of the efficacy and safety of ciprofloxacin in the treatment of chronic otitis. Chemotherapy 40 Suppl. 1 (1994) 29-34
-
(1994)
Chemotherapy
, vol.40
, Issue.SUPPL. 1
, pp. 29-34
-
-
Fombeur, J.P.1
Barrault, S.2
Koubbi, G.3
Laurier, J.N.4
Ebbo, D.5
Lecomte, F.6
-
22
-
-
0027161344
-
Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients
-
Forrest A., Nix D.E., Ballow C.H., Goss T.F., Birmingham M.C., and Schentag J.J. Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients. Antimicrob Agents Chemother 37 5 (1993) 1073-1081
-
(1993)
Antimicrob Agents Chemother
, vol.37
, Issue.5
, pp. 1073-1081
-
-
Forrest, A.1
Nix, D.E.2
Ballow, C.H.3
Goss, T.F.4
Birmingham, M.C.5
Schentag, J.J.6
-
23
-
-
0027197110
-
Development of a population pharmacokinetic model and optimal sampling strategies for intravenous ciprofloxacin
-
Forrest A., Ballow C.H., Nix D.E., Birmingham M.C., and Schentag J.J. Development of a population pharmacokinetic model and optimal sampling strategies for intravenous ciprofloxacin. Antimicrob Agents Chemother 37 5 (1993) 1065-1072
-
(1993)
Antimicrob Agents Chemother
, vol.37
, Issue.5
, pp. 1065-1072
-
-
Forrest, A.1
Ballow, C.H.2
Nix, D.E.3
Birmingham, M.C.4
Schentag, J.J.5
-
24
-
-
0023106978
-
Single-dose ciprofloxacin at 100 versus 250 mg for treatment of uncomplicated urinary tract infections in women
-
Garlando F., Rietiker S., Tauber M.G., Flepp M., Meier B., and Luthy R. Single-dose ciprofloxacin at 100 versus 250 mg for treatment of uncomplicated urinary tract infections in women. Antimicrob Agents Chemother 31 2 (1987) 354-356
-
(1987)
Antimicrob Agents Chemother
, vol.31
, Issue.2
, pp. 354-356
-
-
Garlando, F.1
Rietiker, S.2
Tauber, M.G.3
Flepp, M.4
Meier, B.5
Luthy, R.6
-
25
-
-
0029091757
-
Comparative assessment of the pharmacokinetics and pharmacodynamics of ciprofloxacin after single i.v. doses of 200 and 400 mg
-
Garraffo R., and Drugeon H.B. Comparative assessment of the pharmacokinetics and pharmacodynamics of ciprofloxacin after single i.v. doses of 200 and 400 mg. Drugs 49 Suppl. 2 (1995) 317-320
-
(1995)
Drugs
, vol.49
, Issue.SUPPL. 2
, pp. 317-320
-
-
Garraffo, R.1
Drugeon, H.B.2
-
26
-
-
0032973850
-
Comparative study of single-dose and three-day therapy for acute uncomplicated cystitis
-
Goto T., Kitagawa T., Kawahara M., Hayami H., and Ohi Y. Comparative study of single-dose and three-day therapy for acute uncomplicated cystitis. Hinyokika Kiyo 45 2 (1999) 85-89
-
(1999)
Hinyokika Kiyo
, vol.45
, Issue.2
, pp. 85-89
-
-
Goto, T.1
Kitagawa, T.2
Kawahara, M.3
Hayami, H.4
Ohi, Y.5
-
27
-
-
0023518275
-
Clinical efficacy of ofloxacin in lower respiratory tract infections. A multicentre study
-
Grassi C., Gialdroni G.G., and Mangiarotti P. Clinical efficacy of ofloxacin in lower respiratory tract infections. A multicentre study. Drugs 34 Suppl. 1 (1987) 80-82
-
(1987)
Drugs
, vol.34
, Issue.SUPPL. 1
, pp. 80-82
-
-
Grassi, C.1
Gialdroni, G.G.2
Mangiarotti, P.3
-
28
-
-
0022858732
-
A multicenter study on clinical efficacy of ofloxacin in respiratory and urinary tract infections
-
Grassi G.G. A multicenter study on clinical efficacy of ofloxacin in respiratory and urinary tract infections. Infection 14 Suppl. 4 (1986) S300-S302
-
(1986)
Infection
, vol.14
, Issue.SUPPL. 4
-
-
Grassi, G.G.1
-
29
-
-
0034933394
-
The efficacy and safety of two oral moxifloxacin regimens compared to oral clarithromycin in the treatment of community-acquired pneumonia
-
Hoeffken G., Meyer H.P., Winter J., and Verhoef L. The efficacy and safety of two oral moxifloxacin regimens compared to oral clarithromycin in the treatment of community-acquired pneumonia. Respir Med 95 7 (2001) 553-564
-
(2001)
Respir Med
, vol.95
, Issue.7
, pp. 553-564
-
-
Hoeffken, G.1
Meyer, H.P.2
Winter, J.3
Verhoef, L.4
-
30
-
-
0027518578
-
Single dose therapy of uncomplicated urinary tract infections in women. Remission rates with ciprofloxacin in two prospective randomized comparative studies]
-
Hoyme U.B., Alimi M., Keuter U., Krasemann C., Krolla H., Moayer M., et al. Single dose therapy of uncomplicated urinary tract infections in women. Remission rates with ciprofloxacin in two prospective randomized comparative studies]. Fortschr Med 111 3 (1993) 45-48
-
(1993)
Fortschr Med
, vol.111
, Issue.3
, pp. 45-48
-
-
Hoyme, U.B.1
Alimi, M.2
Keuter, U.3
Krasemann, C.4
Krolla, H.5
Moayer, M.6
-
31
-
-
0030907628
-
Modeling the response of pneumonia to antimicrobial therapy
-
Hyatt J.M., Luzier A.B., Forrest A., Ballow C.H., and Schentag J.J. Modeling the response of pneumonia to antimicrobial therapy. Antimicrob Agents Chemother 41 6 (1997) 1269-1274
-
(1997)
Antimicrob Agents Chemother
, vol.41
, Issue.6
, pp. 1269-1274
-
-
Hyatt, J.M.1
Luzier, A.B.2
Forrest, A.3
Ballow, C.H.4
Schentag, J.J.5
-
32
-
-
0027418043
-
Multicenter study of single-dose and multiple-dose fleroxacin versus ciprofloxacin in the treatment of uncomplicated urinary tract infections
-
Iravani A. Multicenter study of single-dose and multiple-dose fleroxacin versus ciprofloxacin in the treatment of uncomplicated urinary tract infections. Am J Med 94 3A (1993) 89S-96S
-
(1993)
Am J Med
, vol.94
, Issue.3 A
-
-
Iravani, A.1
-
33
-
-
0023613862
-
Norfloxacin in the treatment of uncomplicated gonococcal infections
-
Kaplowitz L.G., Vishniavsky N., Evans T., Vartivarian S., Dalton H., Simpson M., et al. Norfloxacin in the treatment of uncomplicated gonococcal infections. Am J Med 82 6B (1987) 35-39
-
(1987)
Am J Med
, vol.82
, Issue.6 B
, pp. 35-39
-
-
Kaplowitz, L.G.1
Vishniavsky, N.2
Evans, T.3
Vartivarian, S.4
Dalton, H.5
Simpson, M.6
-
34
-
-
0026319883
-
Value of single-dose ciprofloxacin in the treatment of acute uncomplicated urinary tract infection in women
-
Karachalios G.N., Georgiopoulos A.N., Nasopoulou-Papadimitriou D.D., and Adracta D.J. Value of single-dose ciprofloxacin in the treatment of acute uncomplicated urinary tract infection in women. Drugs Exp Clin Res 17 10-11 (1991) 521-524
-
(1991)
Drugs Exp Clin Res
, vol.17
, Issue.10-11
, pp. 521-524
-
-
Karachalios, G.N.1
Georgiopoulos, A.N.2
Nasopoulou-Papadimitriou, D.D.3
Adracta, D.J.4
-
35
-
-
0024368510
-
Efficacy and safety of higher-dose intravenous ciprofloxacin in severe hospital-acquired infections
-
Kljucar S., Heimesaat M., von Pritzbuer E., Timm J., Scholl H., and Beermann D. Efficacy and safety of higher-dose intravenous ciprofloxacin in severe hospital-acquired infections. Am J Med 87 5A (1989) 52S-56S
-
(1989)
Am J Med
, vol.87
, Issue.5 A
-
-
Kljucar, S.1
Heimesaat, M.2
von Pritzbuer, E.3
Timm, J.4
Scholl, H.5
Beermann, D.6
-
36
-
-
0032966498
-
Ciprofloxacin once versus twice daily in the treatment of complicated urinary tract infections. German Ciprofloxacin UTI Study Group
-
Krcmery S., and Naber K.G. Ciprofloxacin once versus twice daily in the treatment of complicated urinary tract infections. German Ciprofloxacin UTI Study Group. Int J Antimicrob Agents 11 2 (1999) 133-138
-
(1999)
Int J Antimicrob Agents
, vol.11
, Issue.2
, pp. 133-138
-
-
Krcmery, S.1
Naber, K.G.2
-
37
-
-
0023025449
-
Clinical, microbiological and pharmacokinetic studies on ofloxacin in acute purulent exacerbations of chronic respiratory disease
-
Maesen F.P., Davies B.I., Baur C., and Sumajow C.A. Clinical, microbiological and pharmacokinetic studies on ofloxacin in acute purulent exacerbations of chronic respiratory disease. J Antimicrob Chemother 18 5 (1986) 629-634
-
(1986)
J Antimicrob Chemother
, vol.18
, Issue.5
, pp. 629-634
-
-
Maesen, F.P.1
Davies, B.I.2
Baur, C.3
Sumajow, C.A.4
-
38
-
-
0036776081
-
Lower dose of ciprofloxacin is adequate for the treatment of Neisseria gonorrhoeae in KwaZulu Natal, South Africa
-
Moodley P., Pillay C., Nzimande G., Coovadia Y.M., and Sturm A.W. Lower dose of ciprofloxacin is adequate for the treatment of Neisseria gonorrhoeae in KwaZulu Natal, South Africa. Int J Antimicrob Agents 20 4 (2002) 248-252
-
(2002)
Int J Antimicrob Agents
, vol.20
, Issue.4
, pp. 248-252
-
-
Moodley, P.1
Pillay, C.2
Nzimande, G.3
Coovadia, Y.M.4
Sturm, A.W.5
-
39
-
-
0023611042
-
Oral ciprofloxacin in the treatment of serious soft tissue and bone infections. Efficacy, safety, and pharmacokinetics
-
Nix D.E., Cumbo T.J., Kuritzky P., DeVito J.M., and Schentag J.J. Oral ciprofloxacin in the treatment of serious soft tissue and bone infections. Efficacy, safety, and pharmacokinetics. Am J Med 82 4A (1987) 146-153
-
(1987)
Am J Med
, vol.82
, Issue.4 A
, pp. 146-153
-
-
Nix, D.E.1
Cumbo, T.J.2
Kuritzky, P.3
DeVito, J.M.4
Schentag, J.J.5
-
40
-
-
0024308248
-
Therapy of lower extremity infections with ciprofloxacin in patients with diabetes mellitus, peripheral vascular disease, or both
-
Peterson L.R., Lissack L.M., Canter K., Fasching C.E., Clabots C., and Gerding D.N. Therapy of lower extremity infections with ciprofloxacin in patients with diabetes mellitus, peripheral vascular disease, or both. Am J Med 86 6 Pt 2 (1989) 801-808
-
(1989)
Am J Med
, vol.86
, Issue.6 PART 2
, pp. 801-808
-
-
Peterson, L.R.1
Lissack, L.M.2
Canter, K.3
Fasching, C.E.4
Clabots, C.5
Gerding, D.N.6
-
41
-
-
0031944261
-
Efficacy and safety of norfloxacin 800 mg once-daily versus norfloxacin 400 mg twice-daily in the treatment of uncomplicated urinary tract infections in women: a double-blind, randomized clinical trial
-
Pimentel F.L., Dolgner A., Guimaraes J., Quintas M., and Mario-Reis J. Efficacy and safety of norfloxacin 800 mg once-daily versus norfloxacin 400 mg twice-daily in the treatment of uncomplicated urinary tract infections in women: a double-blind, randomized clinical trial. J Chemother 10 2 (1998) 122-127
-
(1998)
J Chemother
, vol.10
, Issue.2
, pp. 122-127
-
-
Pimentel, F.L.1
Dolgner, A.2
Guimaraes, J.3
Quintas, M.4
Mario-Reis, J.5
-
42
-
-
29944439506
-
A trial of high-dose, short-course levofloxacin for the treatment of acute bacterial sinusitis
-
Poole M., Anon, Paglia M., Xiang J., Khashab M., and Kahn J. A trial of high-dose, short-course levofloxacin for the treatment of acute bacterial sinusitis. Otolaryngol Head Neck Surg 134 1 (2006) 10-17
-
(2006)
Otolaryngol Head Neck Surg
, vol.134
, Issue.1
, pp. 10-17
-
-
Poole, M.1
Paglia, M.2
Xiang, J.3
Khashab, M.4
Kahn, J.5
-
43
-
-
0031905679
-
Efficacy and tolerability of twice-daily ciprofloxacin 750 mg in the treatment of patients with acute exacerbations of chronic bronchitis and pneumonia
-
Pryka R., Kowalsky S., and Haverstock D. Efficacy and tolerability of twice-daily ciprofloxacin 750 mg in the treatment of patients with acute exacerbations of chronic bronchitis and pneumonia. Clin Ther 20 1 (1998) 141-155
-
(1998)
Clin Ther
, vol.20
, Issue.1
, pp. 141-155
-
-
Pryka, R.1
Kowalsky, S.2
Haverstock, D.3
-
44
-
-
0028183191
-
[The efficacy and tolerance of Bay-o-9867 (ciprofloxacin. in the treatment of infections of the urinary tract and of the lower respiratory tract]
-
Quartieri F., Bolognesi S., and Sconosciuto F. [The efficacy and tolerance of Bay-o-9867 (ciprofloxacin. in the treatment of infections of the urinary tract and of the lower respiratory tract]. Recenti Prog Med 85 2 (1994) 96-100
-
(1994)
Recenti Prog Med
, vol.85
, Issue.2
, pp. 96-100
-
-
Quartieri, F.1
Bolognesi, S.2
Sconosciuto, F.3
-
45
-
-
9044223656
-
Ofloxacin once daily versus twice daily in community-acquired pneumonia and acute exacerbation of chronic bronchitis. A randomized multicenter study
-
Rayman J., Krchnavy M., Balciar P., Duchon J., Fortunik J., Faith L., et al. Ofloxacin once daily versus twice daily in community-acquired pneumonia and acute exacerbation of chronic bronchitis. A randomized multicenter study. Chemotherapy 42 3 (1996) 227-230
-
(1996)
Chemotherapy
, vol.42
, Issue.3
, pp. 227-230
-
-
Rayman, J.1
Krchnavy, M.2
Balciar, P.3
Duchon, J.4
Fortunik, J.5
Faith, L.6
-
46
-
-
0024788087
-
Single-dose ciprofloxacin in the treatment of uncomplicated urinary tract infection in women
-
Raz R., Rottensterich E., Hefter H., Kennes Y., and Potasman I. Single-dose ciprofloxacin in the treatment of uncomplicated urinary tract infection in women. Eur J Clin Microbiol Infect Dis 8 12 (1989) 1040-1042
-
(1989)
Eur J Clin Microbiol Infect Dis
, vol.8
, Issue.12
, pp. 1040-1042
-
-
Raz, R.1
Rottensterich, E.2
Hefter, H.3
Kennes, Y.4
Potasman, I.5
-
47
-
-
0023475835
-
Ofloxacin in respiratory tract infection. A review of the results of clinical trials in Japan
-
Saito A., Katsu M., Saito A., and Soejima R. Ofloxacin in respiratory tract infection. A review of the results of clinical trials in Japan. Drugs 34 Suppl. 1 (1987) 83-89
-
(1987)
Drugs
, vol.34
, Issue.SUPPL. 1
, pp. 83-89
-
-
Saito, A.1
Katsu, M.2
Saito, A.3
Soejima, R.4
-
48
-
-
0023899609
-
Worldwide clinical data on efficacy and safety of ciprofloxacin
-
Schacht P., Arcieri G., Branolte J., Bruck H., Chysky V., Griffith E., et al. Worldwide clinical data on efficacy and safety of ciprofloxacin. Infection 16 Suppl. 1 (1988) S29-S43
-
(1988)
Infection
, vol.16
, Issue.SUPPL. 1
-
-
Schacht, P.1
Arcieri, G.2
Branolte, J.3
Bruck, H.4
Chysky, V.5
Griffith, E.6
-
49
-
-
0023609577
-
Randomized study of two dosage regimens of ciprofloxacin for treating chronic bronchopulmonary infection in patients with cystic fibrosis
-
Shalit I., Stutman H.R., Marks M.I., Chartrand S.A., and Hilman B.C. Randomized study of two dosage regimens of ciprofloxacin for treating chronic bronchopulmonary infection in patients with cystic fibrosis. Am J Med 82 4A (1987) 189-195
-
(1987)
Am J Med
, vol.82
, Issue.4 A
, pp. 189-195
-
-
Shalit, I.1
Stutman, H.R.2
Marks, M.I.3
Chartrand, S.A.4
Hilman, B.C.5
-
50
-
-
0029116216
-
Oral levofloxacin 600 mg and 300 mg daily doses in difficult-to-treat respiratory infections
-
Shishido H., Furukawa K., Nagai H., Kawakami K., and Kono H. Oral levofloxacin 600 mg and 300 mg daily doses in difficult-to-treat respiratory infections. Drugs 49 Suppl. 2 (1995) 433-435
-
(1995)
Drugs
, vol.49
, Issue.SUPPL. 2
, pp. 433-435
-
-
Shishido, H.1
Furukawa, K.2
Nagai, H.3
Kawakami, K.4
Kono, H.5
-
51
-
-
0023748853
-
Therapy of acute and chronic gram-negative osteomyelitis with ciprofloxacin. Report from a Swedish Study Group
-
Swedish Study Group. Therapy of acute and chronic gram-negative osteomyelitis with ciprofloxacin. Report from a Swedish Study Group. J Antimicrob Chemother 22 2 (1988) 221-228
-
(1988)
J Antimicrob Chemother
, vol.22
, Issue.2
, pp. 221-228
-
-
Swedish Study Group1
-
52
-
-
0033802398
-
Oral ciprofloxacin after a short course of intravenous ciprofloxacin in the treatment of spontaneous bacterial peritonitis: results of a multicenter, randomized study
-
Terg R., Cobas S., Fassio E., Landeira G., Rios B., Vasen W., et al. Oral ciprofloxacin after a short course of intravenous ciprofloxacin in the treatment of spontaneous bacterial peritonitis: results of a multicenter, randomized study. J Hepatol 33 4 (2000) 564-569
-
(2000)
J Hepatol
, vol.33
, Issue.4
, pp. 564-569
-
-
Terg, R.1
Cobas, S.2
Fassio, E.3
Landeira, G.4
Rios, B.5
Vasen, W.6
-
53
-
-
0032171550
-
Effects of oral ciprofloxacin on aerobic gram-negative fecal flora in patients with cirrhosis: results of short- and long-term administration, with daily and weekly dosages
-
Terg R., Llano K., Cobas S.M., Brotto C., Barrios A., Levi D., et al. Effects of oral ciprofloxacin on aerobic gram-negative fecal flora in patients with cirrhosis: results of short- and long-term administration, with daily and weekly dosages. J Hepatol 29 3 (1998) 437-442
-
(1998)
J Hepatol
, vol.29
, Issue.3
, pp. 437-442
-
-
Terg, R.1
Llano, K.2
Cobas, S.M.3
Brotto, C.4
Barrios, A.5
Levi, D.6
-
54
-
-
0027068199
-
Randomized prospective study comparing two dosage regimens of ciprofloxacin for the treatment of typhoid fever
-
Uwaydah A.K., al Soub H., and Matar I. Randomized prospective study comparing two dosage regimens of ciprofloxacin for the treatment of typhoid fever. J Antimicrob Chemother 30 5 (1992) 707-711
-
(1992)
J Antimicrob Chemother
, vol.30
, Issue.5
, pp. 707-711
-
-
Uwaydah, A.K.1
al Soub, H.2
Matar, I.3
-
55
-
-
0025008720
-
Double-blind, dose-range-finding study of fleroxacin (RO 23-6240; AM-833. for treatment of complicated urinary tract infections
-
Wolfhagen M.J., Hoepelman A.I., and Verhoef J. Double-blind, dose-range-finding study of fleroxacin (RO 23-6240; AM-833. for treatment of complicated urinary tract infections. Antimicrob Agents Chemother 34 3 (1990) 409-412
-
(1990)
Antimicrob Agents Chemother
, vol.34
, Issue.3
, pp. 409-412
-
-
Wolfhagen, M.J.1
Hoepelman, A.I.2
Verhoef, J.3
-
57
-
-
0026577089
-
Prophylactic ciprofloxacin for catheter-associated urinary-tract infection
-
van der Wall E., Verkooyen R.P., Mintjes-de Groot J., Oostinga J., van Dijk A., Hustinx W.N., et al. Prophylactic ciprofloxacin for catheter-associated urinary-tract infection. Lancet 339 8799 (1992) 946-951
-
(1992)
Lancet
, vol.339
, Issue.8799
, pp. 946-951
-
-
van der Wall, E.1
Verkooyen, R.P.2
Mintjes-de Groot, J.3
Oostinga, J.4
van Dijk, A.5
Hustinx, W.N.6
|